| Patent | Date |
|---|
Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration
App 20220089606 - McChesney; James D. ; et al. | 2022-03-24 |
Biologically active taxane analogs and methods of treatment by oral administration
Grant 11,220,512 - McChesney , et al. January 11, 2 | 2022-01-11 |
Taxane Analogs for the Treatment of Brain Cancer
App 20210401797 - MCCHESNEY; James D. ; et al. | 2021-12-30 |
Taxane analogs for the treatment of brain cancer
Grant 11,147,793 - McChesney , et al. October 19, 2 | 2021-10-19 |
Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration
App 20200347076 - McChesney; James D. ; et al. | 2020-11-05 |
Biologically active taxane analogs and methods of treatment by oral administration
Grant 10,745,408 - McChesney , et al. A | 2020-08-18 |
Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration
App 20200002351 - McChesney; James D. ; et al. | 2020-01-02 |
Biologically active taxane analogs and methods of treatment by oral administration
Grant 10,450,323 - McChesney , et al. Oc | 2019-10-22 |
Taxane Analogs for the Treatment of Brain Cancer
App 20190046501 - McChesney; James D. ; et al. | 2019-02-14 |
Taxane analogs for the treatment of brain cancer
Grant 10,143,677 - McChesney , et al. De | 2018-12-04 |
PFKFB3 inhibit and methods of use as an anti-cancer therapeutic
Grant 10,010,542 - Tapolsky , et al. July 3, 2 | 2018-07-03 |
Taxane Analogs for the Treatment of Brain Cancer
App 20180117002 - McChesney; James D. ; et al. | 2018-05-03 |
Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration
App 20180105535 - McChesney; James D. ; et al. | 2018-04-19 |
Biologically active taxane analogs and methods of treatment by oral administration
Grant 9,802,951 - McChesney , et al. October 31, 2 | 2017-10-31 |
Taxane Analogs for the Treatment of Brain Cancer
App 20170273942 - McChesney; James D. ; et al. | 2017-09-28 |
Pfkfb3 Inhibit And Methods Of Use As An Anti-cancer Therapeutic
App 20170258783 - Tapolsky; Gilles H. ; et al. | 2017-09-14 |
PFKFB3 inhibitor and methods of use as an anti-cancer therapeutic
Grant 9,649,305 - Tapolsky , et al. May 16, 2 | 2017-05-16 |
Modified Dna Quadruplex-forming Oligonucleotides And Methods Of Use
App 20160281090 - Tapolsky; Gilles H. | 2016-09-29 |
Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics
Grant 9,403,769 - Chand , et al. August 2, 2 | 2016-08-02 |
Pharmaceutical Carrier Device Suitable For Delivery Of Pharmaceutical Compounds To Mucosal Surfaces
App 20160101061 - Tapolsky; Gilles H. ; et al. | 2016-04-14 |
Pharmaceutical Carrier Device Suitable For Delivery Of Pharmaceutical Compounds To Mucosal Surfaces
App 20150118285 - Tapolsky; Gilles H. ; et al. | 2015-04-30 |
Pfkfb3 Inhibitor And Methods Of Use As An Anti-cancer Therapeutic
App 20150064175 - Tapolsky; Gilles H. ; et al. | 2015-03-05 |
Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration
App 20140023699 - McChesney; James D. ; et al. | 2014-01-23 |
Pharmaceutical Carrier Device Suitable For Delivery Of Pharmaceutical Compounds To Mucosal Surfaces
App 20130344127 - Tapolsky; Gilles H. ; et al. | 2013-12-26 |
Small Molecule Inhibitors of PFKFB3 and Glycolytic Flux and Their Methods of Use as Anti-Cancer Therapeutics
App 20130059879 - Chand; Pooran ; et al. | 2013-03-07 |
Pharmaceutical Carrier Device Suitable For Delivery Of Pharmaceutical Compounds To Mucosal Surfaces
App 20120231064 - Tapolsky; Gilles H. ; et al. | 2012-09-13 |
Pharmaceutical Carrier Device Suitable For Delivery Of Pharmaceutical Compounds To Mucosal Surfaces
App 20120027839 - Tapolsky; Gilles H. ; et al. | 2012-02-02 |
Small-Molecule Choline Kinase Inhibitors as Anti-Cancer Therapeutics
App 20110257211 - Chand; Pooran ; et al. | 2011-10-20 |
Pharmaceutical Carrier Device Suitable For Delivery Of Pharmaceutical Compounds To Mucosal Surfaces
App 20100003308 - TAPOLSKY; Gilles H. ; et al. | 2010-01-07 |
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
Grant 7,579,019 - Tapolsky , et al. August 25, 2 | 2009-08-25 |
Pharmaceutical Carrier Device Suitable For Delivery Of Pharmaceutical Compounds To Mucosal Surfaces
App 20080254105 - Tapolsky; Gilles H. ; et al. | 2008-10-16 |
Magnetically Targetable Mitomycin C Compositions and Methods of Their Use
App 20070274907 - Li; Yuhua ; et al. | 2007-11-29 |
Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
App 20060204442 - Tapolsky; Gilles H. ; et al. | 2006-09-14 |
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
App 20050147658 - Tapolsky, Gilles H. ; et al. | 2005-07-07 |
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
App 20050048102 - Tapolsky, Gilles H. ; et al. | 2005-03-03 |
Pharmaceutical preparation applicable to mucosal surfaces and body tissues
Grant 6,290,984 - Tapolsky , et al. September 18, 2 | 2001-09-18 |
Bioerodable film for delivery of pharmaceutical compounds of mucosal surfaces
Grant 6,159,498 - Tapolsky , et al. December 12, 2 | 2000-12-12 |
Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
Grant 6,103,266 - Tapolsky , et al. August 15, 2 | 2000-08-15 |
Pharmaceutical preparation applicable to mucosal surfaces and body tissues
Grant 5,955,097 - Tapolsky , et al. September 21, 1 | 1999-09-21 |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
Grant 5,800,832 - Tapolsky , et al. September 1, 1 | 1998-09-01 |
| 